Response of viral specific CD4 T cells to in vitro stimulation with vaccine and wild Measles virus strains in vaccinated and naturally infected subjects

• Autorzy: Czescik A. , Dunal-Szczepaniak M. , Trzcinska A. , Siennicka J.
• Języki publikacji: EN

Abstrakty

EN

With the implementation of the WHO strategic plan for the elimination of measles, the number of measles cases in European Region has decreased. However, outbreaks are still observed. Although most measles cases affect unvaccinated individuals, cases with vaccinated persons are also reported. Furthermore, it was described that a high percentage of young people in Poland exhibit no presence of anti-MeV IgG despite the high level of vaccination covering no less than 97% of the Polish population. Strong evidence exists that immunity to measles is complex and depends on both the humoral and cellular response and although antibodies have been used as correlates of immunity, it is increasingly being considered that antibody-based definitions of vaccine success or failure may be incomplete. Here, we investigated immunity to measles as the reactivity of CD4 T cells to stimulation with vaccine as well as wild strains of measles virus (MeV) isolated in Poland, in young vaccinated persons and subjects infected naturally. Evidence for the presence of MeV-specific memory cells years after infection or vaccination was found, however the cells of vaccinees and naturally infected subjects reacted differently in contact with wild and vaccine MeV strains. Furthermore, the presence of a significant proportion of non-responder vaccinees was observed. In conclusion, our results may have implications for studies on the monitoring of the complexity of post-vaccine immune response.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2014
• Tom: 63
• Numer: 2
• Opis fizyczny: p.203-209,fig.,ref.

Twórcy

autor

Czescik A.

• Department of Virology, National Institute of Public Health–National Institute of Hygiene, Chocimska no 24, 00-791 Warsaw, Poland

autor

Dunal-Szczepaniak M.

• Department of Virology, National Institute of Public Health–National Institute of Hygiene, Chocimska no 24, 00-791 Warsaw, Poland

autor

Trzcinska A.

• Department of Virology, National Institute of Public Health–National Institute of Hygiene, Chocimska no 24, 00-791 Warsaw, Poland

autor

Siennicka J.

• Department of Virology, National Institute of Public Health–National Institute of Hygiene, Chocimska no 24, 00-791 Warsaw, Poland

Bibliografia

• Czarkowski M.P., E. Cieleba, P. Dacka and B. Kondej. 2007. Infectious diseases and poisonings in Poland in 2006. NIZP-PZH, GIS, Warsaw.
• Częścik A., M. Dunal-Szczepaniak, A. Trzcińska and J. Siennicka. 2012. Presence of IgG class antibodies anti measles virus in sera of subjects in different age. Med. Dośw. Mikrobiol. 64: 73–78.
• Sadowska-Galera M. 2009. Initial results and evaluation of IgG antibody levels for rubella, mumps, measles and chickenpox viruses in young adults born in 1989. Przegl. Epidemiol. 63: 365–369.
• Czarkowski M.P., B. Kondej, E. Cieląbek and E. Staszewska. 2010. Vaccination in Poland in 2010. NIZP-PZH, GIS, Warsaw.
• Chen R.T., L.E. Markowitz, P. Albrecht, J.A. Stewart, L.M. Mofenson, S.R. 1990. Preblud and W.A. Orenstein. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162: 1036–1042.
• Janaszek W., W. Gut and N.J. Gay. 2000. The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population. Epidemiol. Infect. 125: 385–392.
• WHO. 1993. Immunological basis for immunization series. Module 7: Measles. World Health Organization, Geneva.
• Nanan R., A. Rauch, E. Kämpgen, S. Niewiesk and H.W. Kreth. 2000. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J. Gen. Virol. 81: 1313–1319.
• Ovsyannikova I.G., N. Dhiman, R.M. Jacobson, R.A. Vierkant and G.A. Poland. 2003. Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin. Diagn. Lab. Immunol. 10: 411–416.
• Naniche D., M. Garenne, C. Rae, M. Manchester, R. Buchta,S.K. Brodine and M.B. Oldstone. 2004. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. J. Infect. Dis. 190: 1387–1395.
• Howe R.C., N. Dhiman, I.G. Ovsyannikova and G.A. Poland. 2005. Induction of CD4 T cell proliferation and in vitro Th1-like cytokine responses to measles virus. Clin. Exp. Immunol. 140: 333–342.
• Haralambieva I.H., I.G. Ovsyannikova, N. Dhiman, R.A. Vierkant, R.M. Jacobson and G.A. Poland. 2010. Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene. J. Med. Virol. 82: 1966–1967.
• Haralambieva I.H., I.G. Ovsyannikova, M. O’Byrne, V.S. Pankratz, R.M. Jacobson and G.A. Poland. 2011. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine 29: 4485–4491.
• Jacobson R.M., I.G. Ovsyannikova, R.A. Vierkant, V.S. Pankratz and G.A. Poland. 2012. Independence of measles-specific humoral and cellular immune responses to vaccination. Hum. Immunol. 73: 474–479.
• Czerkinsky C.C., L.A. Nilsson, H. Nygren, O. Ouchterlony and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65: 109–121.
• Altman J.D., P.A. Moss, P.J. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell JI, A.J. McMichael and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94–96.
• Waldrop S.L., C.J. Pitcher, D.M. Peterson, V.C. Maino andL.J. Picker. 1997. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99: 1739–1750.
• Christenson B. and M. Böttiger. 1994. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 12: 129–133.
• Mossong J., D.J. Nokes, W.J. Edmunds, M.J. Cox, S. Ratnam and C.P. Muller. 1999. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am.J. Epidemiol. 150: 1238–1249.
• Dhiman N., I.G. Ovsyannikova, J.E. Ryan, R.M. Jacobson,R.A. Vierkant, V.S. Pankratz, S.J. Jacobsen and G.A. Poland.2005. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin. Exp. Immunol. 142: 498–504.
• Homann D., L. Teyton and M.B. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7: 913–919.
• Halwani R., M. Doroudchi, B. Yassine-Diab, L. Janbazian, Y. Shi, E.A. Said, E.K. Haddad and R.P. Sékaly. 2006. Generation and maintenance of human memory cells during viral infection. Springer Semin. Immunopathol. 28: 197–208.